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ABSTRACT 
In this study, we hypothesized that herpes viruses, EBV and/or HCMV contribute 
to endodontic disease via herpes virus–bacterium–host response interactions.  In our in 
vitro study, we investigated potential pathogenic interactions between Epstein-Barr virus 
(EBV) and the Gram-positive bacterium, Enterococcus faecalis.  In our in vivo study, we 
hypothesized that individuals with symptomatic endodontic disease would have elevated 
bacterial/viral replication and inflammation compared to that of asymptomatic 
individuals. 
In our in vitro study, EBV reactivation within latently infected cells was assessed 
following exposure to E. faecalis metabolic end products and cell wall by quantitative 
PCR of media for EBV virions and of cellular mRNA for viral gene expression.  To 
determine potential mechanisms of EBV reactivation, the effect of E. faecalis mediated 
activation of latent EBV was evaluated when the cells were simultaneously exposed to 
bacterial products and specific pharmacologic inhibitors of signal transduction pathways.  
The growth and virulent gene expression of E. faecalis when exposed to lymphoid cells 
with and without latent EBV infection were evaluated using real-time PCR.  To assess 
the role of viral and bacterial interaction on the host response, transcription of cellular 
inflammatory genes was determined using real-time RT-PCR.   
In our in vivo study, twenty pulp tissue samples were collected from patients 
diagnosed with irreversible pulpits, 10 with symptoms of self-reported severe pain (>7 on 
10-point pain scale, Symptomatic) and 10 without self-reported pain (Asymptomatic), 
respectively.  As controls, ten pulp tissue samples were collected from extracted healthy 
3rd molars, which had no fracture, caries, or periodontal disease.  Additionally, two 
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periapical tissue samples were collected during apicoectomy from patients with persistent 
periapical infection after root canal treatment.  Total DNA and RNA were extracted from 
pulp tissue using DNeasy and RNeasy kit (Qiagen), respectively. Quantification of  total 
bacteria, Streptococcus sp., Lactobacillus sp., Fusobacterium sp., Actinomyces sp., E. 
faecalis, EBV and Human Cytomegalovirus (HCMV) were assessed using quantitative 
PCR (qPCR) for consensus or organism specific DNA.  Total bacterial RNA was used to 
indicate transcriptional activity and was evaluated using quantitative reverse-transcriptase 
PCR (RT-PCR).  The expression of inflammatory genes including IL-6, IL-10, TNF-α, 
TNF-β and IFN-β was evaluated using quantitative reverse-transcriptase PCR.   
The result from our in vitro study showed that lipoteichoic acid (LTA), a cell wall 
component of E. faecalis, can re-activate latent EBV.  E. faecalis LTA -mediated 
induction of lytic EBV infection was significantly reduced by both a TLR2 antagonist 
and an inhibitor of the NF-kB/Ikb pathway.  Interestingly, the growth of E. faecalis 
increased 5-fold with presence of EBV.  The expression of E. faecalis virulence genes 
were significantly increased in presence of EBV.  Proinflammatory cytokine expression 
was also significantly higher in the presence of EBV.   
The result from our in vivo study showed that a greater than 5-fold increase was 
detected in bacterial DNA levels from pulp tissue of symptomatic patients compared to 
controls (P=0.004).  These differences were not detected between asymptomatic patients 
and the control (P= 0.275).  Likewise, total bacterial activity (RNA) was 5-fold higher in 
symptomatic patients than the asymptomatic (P=0.027).  Lactobacillus sp., 
Fusobacterium sp. and Actinomyces sp. were present in inflamed pulp tissue, but not in 
healthy pulp tissue.  Among the samples with Streptococcus sp., asymptomatic pulp 
iv 
 
tissues had 30 fold higher levels, and symptomatic pulp tissues had  5 folds higher levels 
detected compared to controls (P=0.001, P=0.003 respectively).   Interestingly, while 
EBV was widely detected, CMV was detected only in periapical tissues.  Greater than a 
30-fold increase in EBV DNA was detected in pulp tissue from symptomatic individuals 
compared to controls (P<0.001).   Further, a 30-fold difference was shown in EBV 
detection in pulp tissue from symptomatic compared to asymptomatic (P=0.028) patients. 
The quantity of EBV in the pulp tissue from asymptomatic patients was comparable to 
the control (P=0.403).   Real-time RT-PCR analysis of inflammatory gene expression in 
pulp tissues detected expression in disease but not within healthy controls.  The IL-6 gene 
was expressed at levels 11-fold higher in symptomatic pulp than in asymptomatic pulp 
(P=0.026).  Regression analysis indicated that inflammatory gene expression levels were 
associated with bacterial transcription and with EBV viral load.  
Collectively, our in vitro results show that E. faecalis and EBV may have 
synergistic effect during inflammatory process.  Our in vivo results suggest a significant 
association between bacteria, EBV and inflammation in symptomatic disease within the 
pulp tissue.  CMV is more tightly associated with chronic infection than acute infection.  
These results support a paradigm shift in which elevated bacterial/viral replication and 
inflammation are associated with endodontic infection.  
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1.1 Endodontic disease is prevalent and one of the major causes for dental pain. 
Endodontic disease denotes inflammation within pulp tissue and around periapical 
tissue.  Endodontic disease is prevalent.  Endodontic therapy was required by 13.4% of 
the Air Force recruits in England in order to maintain the new recruits dentally fit for 
their first 5 years in the service (1).  The needs for endodontic therapy was as high as 
31% in Moscow student in a recent epidemiologic report (2).  Periapical disease is 
prevalent and was evident in 4.1% of all teeth in a US population (3).  Furthermore, 
endodontic disease is considered a major cause for dental pain (4).  Dental pain is highly 
prevalent among the general population.  Its reported prevalence in community dwelling 
adults ranges from 12 to 40% (5).  According to the Executive Summary of the Surgeon 
General's report published in 2000 (6), 22% of adults reported some form of orofacial 
pain in the past 6 months.  Every year, about 15 million working days are lost because of 
dental pain in the United States (6).  In addition to direct costs for absenteeism, the 
overall burden must be considerably higher because of pain affecting function as well as 
quality of life.  The majority of dental pain is attributable to endodontic diseases (7-9).  In 
approximately 90% of dental emergencies with pain as a symptom, the pain is pulpal or 
periapical (10). 
 
1.2  The diagnosis and classification of endodontic diseases  
The classification and diagnosis of endodontic diseases is as follows according to 
the American Board of Endodontics’ Pulpal and Periapical Definitions 
(http://www.aae.org/certboard/currentnews/). 
 
 
3 
Pulpal 
Normal pulp. A clinical diagnostic category in which the pulp is symptom free 
and normally responsive to vitality testing.  
Reversible pulpitis. A clinical diagnosis based on subjective and objective 
findings indicating that the inflammation should resolve and the pulp return to normal. 
Irreversible pulpitis. A clinical diagnosis based on subjective and objective 
findings indicating that the vital inflamed pulp is incapable of healing. 
Additional Descriptions 
Symptomatic. Lingering thermal pain, spontaneous pain, referred pain. 
Asymptomatic. No clinical symptoms, but inflammation produced by caries, caries 
excavation, trauma. 
Pulp necrosis. A clinical diagnostic category indicating death of the dental pulp. 
The pulp is nonresponsive to vitality testing. 
Previously treated. A clinical diagnostic category indicating that the tooth has 
been endodontically treated and the canals are obturated with various filling materials 
other that intracanal medicaments. 
Previously initiated therapy. A clinical diagnostic category indicating that the 
tooth has been previously treated by partial endodontic therapy (eg, pulpotomy or 
pulpectomy). 
Apical (Periapical) 
Normal apical tissues. Teeth with normal periradicular tissues that are not 
abnormally sensitive to percussion or palpation testing.  The lamina dura surrounding the 
root is intact and the periodontal ligament space in uniform. 
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Symptomatic apical periodontitis. Inflammation, usually of the apical 
periodontium, producing clinical symptoms, including painful response to biting and 
percussion. It may or may not be associated with an apical radiolucent area. 
Asymptomatic apical periodontitis. Inflammation and destruction of apical 
periodontium that is of pulpal origin, appears as an apical radiolucent area, and does not 
produce clinical symptoms. 
Acute apical abscess. An inflammatory reaction to pulpal infection and necrosis 
characterized by pain onset, spontaneous pain, tenderness of the tooth to pressure, pus 
formation and swelling of associated tissues. 
Chronic apical abscess. An inflammatory reaction to pulpal infection and 
necrosis characterized by gradual onset, little or no discomfort, and the intermittent 
discharge of pus through an associated sinus tract. 
 
1.3 Pathogenesis of endodontic diseases  
It is widely accepted that the most common cause of pulp and periapical diseases 
is the presence of bacteria within the involved tooth and the most common pathways of 
entry for these bacteria are via caries, cracks, fractures and open restoration margins. 
Other possible pathways for bacterial penetration are associated with periodontal disease 
and dental trauma (11).  
After bacteria or their byproducts enter a tooth’s pulp chamber, endodontic 
inflammation occurs.  Acute endodontic inflammation generally manifests as a toothache, 
whereas chronic endodontic inflammation can remain asymptomatic for months or years.  
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The progression of endodontic diseases is the balance between invading bacteria/bacterial 
byproduct and host immune response (Figure 1-1).  
(A)            (B)     
Figure 1-1 (A) Simplified schematic of progression of endodontic diseases from 
pulpal infection to periapical infection; (B) Simplified schematic of apical 
periodontitis, which is the body’s defense response to the destruction of the tooth pulp 
and the hostile  forei n occupation ’ of the root canal.  he microbial and host-defense 
forces clash and destroy much of the periapical tissues, causing the formation of 
different categories of apical periodontal lesions. (12)   
 
1.3.1 The bacterial role in endodontic disease is well-established.  
Endodontic disease is a polymicrobial, multistage inflammatory response initiated 
by the migration of opportunistic microorganisms from the oral cavity.  This leads to an 
influx of inflammatory cells, resulting in pulpitis and periapical periodontitis.  The 
significance of bacteria in the progression and perpetuation of pulpal and periradicular 
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inflammatory diseases is indisputable (13-14).  Endodontic infections involve multiple 
bacteria.  Two hundred different species have been identified within infected root canals, 
usually in combinations of 4-7 species (spp.) per canal (15-17).  Of these, however, 
between 15 to 30 have been most frequently detected in infected root canals, including 
Fusobacterium nucleatum, Streptococcus spp., Lactobacillus spp. and Actinomyces spp. 
(16-18).  Because the root canal environment and nutritional supply govern the dynamics 
of the microbial flora, the bacteria present in the root canal depend on the stage of the 
infection.  
Primary intraradicular infection is dominated by anaerobic bacteria that includes 
both Gram –negative bacteria such as Porphyromonas, Fusobacterium, Tannerella 
forsythia (formerly Bacteroides forsythus), and Gram-positive bacteria such as 
Pseudoramibacter alactolyticus, Streptococcus, Actinomyces (19).  After 
instrumentation/medication, Gram-negative bacteria are usually eliminated after 
treatment procedures (19).  Gram-positive bacteria are more frequently present, including 
Streptococci, Pavimonas micra, Actinomyces, Propionibacterium, lactobacilli, 
Enterococcus faecalis, and Olsenella uli.  Persistent or secondary intraradicular infection 
is characterized by persistence or appearance of apical periodontitis after treatment.  The 
frequently detected bacteria in persistent infection include Propionibacterium acnes, 
Propionibacterium propionicum, Actinomyces naeslundii, Actinomyces odontolyticus, 
Prevotella intermedia, Anaerococcus prevotii, Eggerthela lenta, E. faecalis, Gemella 
morbillorum, P. micra, P. alactolyticus, Streptococcus anginosus, Streptococcus mitis, F. 
nucleatum, and Candida albicans.  Extraradicular infection is characterized by microbial 
invasion of and proliferation in the inflamed periradicular tissues, and is derived from 
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intraradicular infection (20).  Extraradicular infection can be dependent on or independent 
of intraradicular infection (19). Species reported by many studies include: Actinomyces 
species, P. acnes, P. propionicum, Porphyromonas gingivalis, Prevotella intermedia, 
Prevotella oralis, P. micra, and F. nucleatum (19).  
 
1.3.2 Bacterial activation of pulpal immune responses contributes to endodontic 
pathogenesis.  
Once bacteria invade into pulp tissue, a wide range of non-specific mediators of 
inflammation such as histamine, bradykinin, serotonin, interleukins (IL) and arachidonic 
acid metabolites are released.  In addition, many neuropeptides (e.g. substance P and 
calcitonin gene-related peptide) are also involved.  Besides non-specific inflammatory 
reactions, immunologic responses may also initiate and perpetuate pulp disease.  In mild-
to-moderate inflammation, cell-mediated immunity predominates.  In severe 
inflammation, the appearance of B cells and plasma cells indicates local antibody 
production, therefore suggesting a predominance of humoral immunity.  Bacterial 
substances may also trigger the complement system via antigen-antibody complexes, 
which become chemotactic for polymorphonuclear leukocytes.  There is a distinct ratio 
difference between T-helper and T-suppressor lymphocytes in reversible and irreversible 
pulpits (21).  Bacteria interact with immune cells via pattern recognition receptors such as 
Toll Like Receptors (TLRs) (Table 1) (22).  Binding of bacterial adjuvants to these 
receptors activates nuclear factor- B (NF B), a central signaling pathway that leads to 
transcription of multiple proinflammatory molecules (23)  All of these inflammation 
factors may contribute to disease progression. 
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Table 1  Pattern-recognition receptors and their ligands (22) 
Pattern-
recognition 
receptors 
Ligands 
TLR1 Borrelia burgdorferi, neisseria, lipoproteins (mycobacteria); triacyl 
lipopeptides (synthetic analogue) 
TLR2 Trypanosomes, mycoplasma, borrelia, listeria, klebsiella, herpes simplex 
virus, zymosan (yeast), lipoteichoic acid and peptidoglycan (Gram+), 
lipoproteins (mycobacteria), atypical lipopolysaccharide  	 ram
  , 
glycolipids, lipoarabinomannan, HSP 70 (endogenous ligand); di- and 
triacyl lipopeptides (synthetic analogue) 
TLR3 Viral double-stranded RNA; Poly I:C (synthetic analogue) 
TLR4 Plant product taxol, mycobacteria, respiratory syncytial virus, fibrinogen 
peptides, bacterial lipopolysaccharides  	 ram
  ,     0  endo enous 
ligand); lipopolysaccharide/lipid A mimetics (synthetic analogue); 
synthetic lipid A, E5564 (fully synthetic small molecule) 
TLR5 Bacterial flagellins; discontinuous 13-amino-acid peptide (synthetic 
analogue) 
TLR6 Zymosan (fungi), lipopeptides (mycoplasma), lipotechoic acid; diacyl 
lipopeptides (synthetic analogue) 
TLR7 Single-stranded RNA, R-837 and R848; imidazole quinolines, i.e. 
Imiquimod, Resiquimod (fully synthetic small molecule); guanosine 
nucleotides, i.e. loxoribine (fully synthetic small molecule) 
TLR8 Single-stranded RNA, R848; imidazole quinolines, i.e. Imiquimod (fully 
synthetic small molecule) 
TLR9 Bacterial DNA, viral DNA, other DNA with low content of non-
methylated CpG sequences; CpG oligonucleotides (synthetic analogue) 
TLR10 
(mouse) 
Unknown 
TLR11 
(mouse) 
Bacterial components from uropathogenic bacteria 
TLR12 
(mouse) 
Unknown 
TLR13 
(mouse) 
Unknown 
NOD1 Bacterial peptidoglycans 
NOD2 Bacterial peptidoglycans 
Macrophage 
mannose 
receptors 
Sulfated sugars, mannose-, fucose- and galactose-modified 
polysaccharides and proteins 
Type 3 
complement 
receptors 
 ymosan particles, β-glucan 
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1.3.3 Association between bacterial number and species and severity of endodontic 
diseases has been indicated.  
The severity of disease clinically is defined as the size of periapical lesions and 
patients’ symptoms, includin  pain and swelling.  In this project, the level of 
inflammatory factors produced within pulp tissue was used as the indication of the 
severity of irreversible pulpitis on a molecular level.  A positive correlation exists 
between the number of bacteria in an infected root canal and the size of periradicular 
radiolucencies (24).  There tends to be an association between different bacterial species 
and different clinical signs and symptoms.  However, the association is not conclusive 
(16, 25).  Whether other pathogens involved in endodontic pathogenic processes could 
affect the above mentioned association is not clear. 
 
1.4  Viral involvement in endodontic diseases.  
As early as 1965, viral involvement in endodontic disease had been investigated 
(26).  Cohen & Shklar (26) in their mice study described that varying degrees of pulpal 
pathosis in noncarious teeth of mice injected at birth with polyoma virus and sacrificed at 
6 to 12 months. In teeth with extensive carious involvement and carious exposures, the 
pulps were found to have undergone complete hemorrhagic necrosis in all cases.  In the 
early 1990s, HIV was detected in pulp and periapical tissue is AIDS patient (27-28).   
Herpes viruses are prevalent in human.  Whether the herpes viruses involved in 
endodontic diseases still needs investigation.  The classification of herpes viruses is listed 
in Table 2. 
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Table 2 Classification of Human Herpes Viruses  
Human 
herpes 
type  
Name  Target cell 
type  
Latency  Transmission  
1 Herpes simplex-1 
(HSV-1) 
Mucoepithelia Neuron Close contact 
2 Herpes simplex-2 
(HSV-2) 
Mucoepithelia Neuron Close contact 
usually sexual 
3 Varicella Zoster 
virus (VSV) 
Mucoepithelia Neuron Contact or 
respiratory route 
4 Epstein-Barr Virus 
(EBV) 
B lymphocyte, 
epithelia 
B lymphocytes Saliva 
5 Cytomegalovirus 
(CMV) 
Epithelia, 
monocytes, 
lymphocytes 
Monocytes, 
lymphocytes 
and possibly 
others 
Contact, blood 
transfusions, 
transplantation, 
congenital 
6 Herpes 
lymphotropic virus 
T lymphocytes 
and others 
T lymphocytes 
and others 
Contact, 
respiratory route 
7 Human herpes virus-
7 (HHV-7) 
T lymphocytes 
and others 
T lymphocytes 
and others 
Unknown 
 
1.4.1 EBV and CMV have emerged as putative pathogens for endodontic disease.  
 During the past decade, herpes viruses have emerged as putative periapical 
pathogens, particularly EBV and CMV (29-32).  EBV is present more frequently in 
endodontic pathoses than in healthy controls (33), thus it may be that herpes viruses play 
a role in the development of symptomatic periapical lesions (31-32).  In a study 
comparing the presence of CMV and EBV in samples from symptomatic versus 
asymptomatic periapical lesions, CMV was detected in 100% of the symptomatic and in 
37% of the asymptomatic study lesions.  In contrast, EBV was identified only in CMV-
infected periapical lesions (32). Teeth with necrotic pulp and periapical lesions harbor 
herpes viruses in periapical granulomatous tissue. The occurrence of these viruses was 
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significantly greater when comparing large versus small periapical lesions, irrespective of 
whether or not the periapical lesions were symptomatic (30).  Thus, herpes viruses, in 
cooperation with endodontic pathogenic bacteria, may play major roles in the 
pathogenesis of aggressive types of periapical pathosis in humans (30).    Li et. al. 
(33)found the EBV DNA and RNA in significantly higher percentages (43.9 and 25.6 
percent, respectively) in endodontic patients than in healthy patients (0 percent). They 
found HCMV DNA and RNA in measurable numbers in endodontic patients (15.9 and 
29.3 percent, respectively) as well as in healthy patients (42.1 and 10.5 percent, 
respectively). The researchers found HSV DNA in low percentages of endodontic 
patients (13.4 percent), and they found VZV in only one endodontic patient. Chen 
et.al.(34) identified HCMV, EBV, herpes simplex virus-1 (HSV-1), and Varicella zoster 
virus (VZV) present in some patients presenting with acute apical abscesses and cellulitis 
of endodontic origin.   
 
1.4.2 EBV and CMV infect immune cells and produce cytokines modulating 
inflammatory response.  
EBV and CMV belong to the herpes virus family, and 60-100% adults are carriers 
of these viruses (35).  EBV infects B-lymphocytes (36), while CMV infects 
monocytes/macrophages, T-lymphocytes, ductal epithelial cells of salivary glands, 
endothelial cells, fibroblasts and polymorphonuclear leukocytes, and establishes latent 
infection mainly in cells of the myeloid lineage (36) (Table 2). 
Herpes viruses may establish latency or a productive (lytic) state of replication.  
In the viral productive cycle, the herpes virus genome is amplified 100- to 1000-fold by 
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the viral replication machinery (36).  Herpes virus infections induce strong innate and 
adaptive antiviral immune responses.  Lytic infection of cells with herpes viruses leads to 
an inhibition of the synthesis of cellular macromolecules.  Herpes viruses evade the 
immune system through a complicated multifactorial mechanism either via NF-    
pathway or another undefined mechanism (36).  EBV latent membrane protein-1 (LMP-
1) has been shown to trigger cellular NF-   and AP-1 activity (37) is essential for EBV-
mediated B-cell immortalization.  Herpes viruses interfere with innate and adaptive 
cellular and humoral immune responses by affecting cytokine production, the activation 
and silencing of natural killer cells, down-modulating antigen presentation in the major 
histocompatibility complex class I and II pathways, and impairing apoptosis (38).  
Cytokines produced in viral infection can significantly modulate the inflammatory 
response and include interleukin (IL)-1β, I -6, IL-1 , tumor necrosis factor α   NF-α , 
interferon (INF)-α β, and INF-  for CMV infection  and I -1β, I -1 receptor antagonist 
(IL-1Ra), IL-6, IL-8, IL-18, TNF-α, INF-α β, INF- , for   V infection (38).  
 
1.5 Synergistic effects between virus and bacteria have been indicated in other 
infectious diseases.  
Synergisms between virus and bacteria have been indicated in other infectious 
diseases such as respiratory tract infection (39) and otitis media (40).  The increase 
evidence supports the concept that the increased susceptibility to bacterial infection of the 
virus-infected host is, at least in part, due to virus-induced alterations of the functional 
integrity of the host immune system (39). This may occur either directly by viral 
interaction with leukocytes or indirectly through virus-induced release of cellular 
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mediators or cytokines.  In addition, cytokines may contribute to the development of 
pathological lesions and clinical symptoms, either alone or in concert with direct 
microbial cytopathic effects (39).  The molecular and genetic basis for viral-bacterial 
synergy has been described in Bovine respiratory disease (BRD) (41).   
A mouse model of synergy between influenza and pneumococcal in pneumonia 
has been established in mice (42).  The study using this model suggests that influenza up-
regulates the platelet-activating factor receptor and thereby potentiates pneumococcal 
adherence and invasion in the lung (42). This bacterium-virus synergy can be regulated 
by stress (43).  Research in otitis media indicated that the etiopathogenesis of acute otitis 
media (AOM) involves viruses, bacteria, and a large network of other factors that affect 
each other in a time-dependent manner. Respiratory viruses play a crucial role in 
initiating the whole cascade of events that ultimately lead to the development of AOM. In 
the middle ear, viruses seem to interact with bacteria and enhance the local inflammatory 
process, which in turn may significantly impair the outcome of the disease (40).   
 
1.6 EBV and CMV effects in endodontic disease may be indirect, via interactions 
with bacteria and the host  
An interaction between viruses and bacteria during inflammation has been found 
(44). The purified major outer membrane component of Gram-negative bacteria, 
lipopolysaccharide (LPS), has been shown to be able to reactivate latent viral infection 
(44).  Both short chain fatty acid-containing spent media and crude spent media 
containing LPS activate signal transduction pathways to allow for herpes virus 
reactivation. On the other hand, destruction of epithelial cells by herpes virus infection 
can facilitate the penetration of bacteria into connective tissue.  Herpes viruses including 
 
 
14 
CMV inhibit the expression of macrophage surface receptors that recognize LPS and 
other components of the Gram-negative bacteria. Furthermore, herpes viruses destroy 
components of the major histocompatibility complex (MHC) pathway within 
macrophages and impair the immune defense in its ability to present antigen, silence 
natural killer cells, stop cell death, and divert antiviral cytokine responses (45-46).  
Therefore, herpes virus infections can promote bacterial colonization and can enhance the 
growth and pathogenicity of bacteria by disprupting several aspects of the host immune 
defense.   
CMV and EBV infections may cause periapical pathosis by inducing cytokine and 
chemokine release from inflammatory or connective tissue cells, or by impairing local 
host defenses, resulting in heightened virulence of resident bacterial pathogens (32).   The 
pathophysiologic mechanisms of severe periapical pathosis and the processes of 
periapical release of herpes virus-associated cytokines are intimately related.  Viral-
bacterial interactions are through both host cells, such as macrophages and leukocytes, 
and inflammatory molecules such as cytokines and chemokines.   
 
1.7  The limitations of previous studies and  hypothesis  
Previous literature indicated that EBV, HCMV involved in endodontic diseases.  
However, majority of the studies have focused solely on the detection of viruses in a non-
quantitative manner.  There have been no mechanisms identified for the role of viral 
infection in endodontic disease.  More importantly, the majority of the studies did not 
take into consideration of bacterial effect when establishing the role of virus in 
endodontic diseases.   
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In this study, we proposed the following models for bacterial and viral 
interactions and their involvement in endodontic diseases (Figure 1-2) and hypothesized 
that herpes viruses, EBV and/or HCMV contribute to endodontic disease via herpes 
virus–bacterium–host response interactions.  In our in vitro study, we investigated 
whether E. faecalis and EBV can facilitate each other’s patho enesis and whether E. 
faecalis re-activate latent EBV in lymphocytes via TLR2 mediate NF-   pathway.  In 
our in vivo study, we investigated whether EBV viral loads were associated with pulpal 
inflammation after adjusting for bacterial activity.   
 
Figure 1-2 Hypothetical model of viral involvement in endodontic disease 
progression via viral-bacterial interaction. Healthy pulp becomes infected with 
bacteria. This results in the recruitment of inflammatory cells which potentially harbor 
latent viruses and re-activation of virus latently resident in the immune cells present in 
the pulp tissue.  The presence of the bacteria and their associated components reactivates 
the virus via TLRs dependent NF-    pathway within these cells resulting in viral 
replication, which influences the inflammatory milieu subsequently promoting disease. 
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ABSTRACT 
Introduction: This study aimed to explore potential pathogenic interactions 
between Epstein-Barr virus (EBV) and the Gram-positive bacterium, Enterococcus 
faecalis.    
Methods: EBV reactivation within latently infected cells was assessed following 
exposure to E. faecalis metabolic end products and cell wall by quantitative PCR of 
media for EBV virions and of cellular mRNA for viral gene expression.  To determine 
potential mechanisms of EBV reactivation, the effect of E. faecalis mediated activation of 
latent EBV was evaluated when the cells were simultaneously exposed to bacterial 
products and specific pharmacologic inhibitors of signal transduction pathways.  The 
growth and virulent gene expression of E. faecalis when exposed to lymphoid cells with 
and without latent EBV infection were evaluated using real-time PCR.  To assess the role 
of viral and bacterial interaction on the host response, transcription of cellular 
inflammatory genes was determined using real-time RT-PCR.   
Results: Lipoteichoic acid (LTA), a cell wall component of E. faecalis, can re-
activate latent EBV.  E. faecalis LTA -mediated induction of lytic EBV infection was 
significantly reduced by both a TLR2 antagonist and an inhibitor of the NF-kB/Ikb 
pathway.  Interestingly, the growth of E. faecalis increased 5-fold with presence of EBV.  
The expression of E. faecalis virulence genes were significantly increased in presence of 
EBV.  Proinflammatory cytokine expression was also significantly higher in the presence 
of EBV.   
Conclusions: Collectively, our results show that E. faecalis and EBV may have 
synergistic effect during inflammatory process.  
 23 
 
INTRODUCTION 
Polymicrobial infections are present throughout the body and play a significant 
role in disease development.  Viral-bacterial synergy in infectious diseases has been 
proposed (1-3).  Epstein-Barr virus (EBV) infections are ubiquitous in the human 
population with 60-100% adults  carrying the virus (3).  Whether EBV-bacterial 
interactions play a role in infectious diseases requires further investigation.   
EBV belongs to the herpes virus family and latently infects B-lymphocytes.  The 
viral life cycle takes approximately 72 hours. Viral gene expression occurs in a 
temporally regulated manner, initiating with expression of the immediate early genes that 
encode regulatory proteins, followed by early gene expression that generally encodes 
enzymes for replicating viral DNA. Lytic infection of cells with the herpes viruses leads 
to an inhibition of the synthesis of cellular macromolecules.  After viral replication has 
commenced, the late genes are expressed that encode structural components of the virion 
(4).     
Herpes viruses may establish latency or can commence a productive (lytic) state 
of replication. In the viral productive cycle, the herpes virus genome is amplified 100- to 
1000-fold by the viral replication machinery, resulting in a significant increase of virion 
production and release (4).   Herpes virus infections often induce strong antiviral innate 
and adaptive immune responses (5).  Herpes viruses interfere with innate and adaptive 
cellular and humoral immune response by affecting cytokine production, the activation 
and silencing of natural killer cells, down-modulating antigen presentation in the major 
histocompatibility complex class I and II pathways, and impairing apoptosis (6).  
Cytokines produced in viral infection can significantly modulate the inflammatory 
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response and include interleukin (IL)-1β, I -1 receptor antagonist (IL-1Ra), IL-6, IL-8, 
IL-18, TNF-α, INF-α β, INF-  (6). EBV latent membrane protein-1 (LMP-1) triggers 
both cellular NF-   and AP-1 activity  and is essential for EBV-mediated B-cell 
immortalization (7). Herpes viruses evade the immune system through a complicated 
multifactorial mechanism either via NF-   pathway or another undefined mechanism (4).   
Enterococci now rank among the top three nosocomial bacterial pathogens(8). 
Two species are common commensal organisms in the intestines of humans: 
Enterococcus faecalis (90-95%) and Enterococcus faecium (5-10%).  Enterococci can 
survive and adapt to adverse conditions such as heat, ethanol, hydrogen peroxide, acidity, 
and alkalinity.  The virulence factors of E. faecalis and their functions have been studied 
extensively, including enterococcal surface protein (ESP) (9), LTA, aggregation 
substance (AS), surface adhesins (Adh), bacteriocins (Bact), binding substance (BS), 
collagen peptides (CP), cytolysin (Cyl), elastase (Elas), gelatinase (Gel), hyaluronidase 
(Hya), and hydrogen peroxide (H2O2) (10).  The virulence factors of E. faecalis stimulate 
PMN leukocytes, lymphocytes, monocytes, and macrophages, causing inflammation (10).  
Bacteria interact with immune cells via Toll Like Receptors (TLRs) (11). Different TLRs 
bind to specific "molecular signatures" of different classes of micro-organisms or to 
individual features present on diverse commensals or pathogens; for example, TLR2, 
lipopeptide; TLR4, lipopolysaccharide; and TLR5, flagellin (11). It has been suggested 
that E faecalis binds to TLR2 via its cell wall component, LTA.  Binding of bacteria to 
these receptors activates nuclear factor- B (NF B), a central signaling pathway that 
initiates transcription of multiple proinflammatory molecules (12).   
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Previous studies have determined a role for bacterial infection in reactivation of 
Kaposi's sarcoma-associated herpesvirus (KSHV) (13).  The interaction between herpes 
virus and bacteria in periapical pathosis has been proposed. The mechanism of the 
interaction has not yet been described. Slots et al.(14) hypothesized that HCMV and EBV 
infections may cause periapical pathosis by inducing cytokine and chemokine release 
from inflammatory or connective tissue cells, or by impairing local host defenses, 
resulting in heightened virulence of resident bacterial pathogens. Host leukocytes are 
often latently infected with viral pathogens, during bacterial mediated endodontic disease 
it is feasible that the presence of leukocytes harboring virus may compound the disease 
process. It may be that the pathophysiologic mechanisms of severe periapical pathosis 
and the processes of periapical release of herpes virus-associated cytokines are intimately 
related.   
Very few studies have investigated interactions between herpesviruses and Gram-
positive bacteria (13, 15).  In this study, we hypothesized that E. faecalis can re-activate 
latent EBV infection.  We further hypothesized EBV infected cells can facilitate E. 
faecalis infection; and EBV-E. faecalis interaction may aggravate the inflammatory 
response. We investigated the mechanism of this reactivation during E. faecalis 
pathogenesis.   
 
MATERIALS AND METHODS 
Cell lines, cell culture, collection of E. faecalis spent medium and cell wall component 
extraction 
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B958 is a latently infected EBV lymphoma-derived cell line. DG75 is an EBV-
negative B lymphoblastoid cell line.  BL 41 with and without latent EBV are lymphoma-
derived cell lines with and without latently infected EBV.  Cell lines were maintained in 
5% CO2 at 37°C in RPMI 1640 medium supplemented with 10% fetal bovine serum 
(FBS) and containing penicillin, streptomycin, sodium pyruvate, and L-glutamine 
(GIBCO-BRL, Gaithersburg, MD). 
E. faecalis strains ER3/2s and ER5/1 were kind gifts from Dr. Christine Sedgley 
(University of Michigan, Ann Arbor, MI).  E. faecalis strains were grown aerobically in 
Brain Heart Infusion (BHI) at 37°C.  Spent medium was collected from cells that were 
harvested from overnight culture at a late exponential stage of growth via centrifugation 
of bacterial culture at 5,000 rpm for 10minutes. The supernatant was filtered through 
0.2 M filter.   he filtrate was added at a 1:20 dilution as spent medium for induction of 
re-activation of latent EBV/HCMV in immune cells.  The crude extraction of cell wall 
component of E. faecalis was performed using lithium chloride method published 
previously (16). 
 
Antibodies and chemicals  
The goat polyclonal antibody against ß-actin was purchased from Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA. The EBV antibody to Early D Antigen (EA-D) was 
obtained from ARUP laboratory (Salt Lake City, UT).  E. faecalis LTA was purchased 
from Sigma (St. Louis, MO).  The I   phosphorylation inhibitor, Bay 11-7082 
(Calbiochem, Gibbstown, NJ) was used to inhibit transcription factor NF-kB activity.  
The monoclonal antibody specific to TLR2, TLA2.1 (eBioscience, San Diego, CA) was 
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applied as the TLR2 antagonist. RQ1 DNase was obtained from Promega, Madison, WI. 
All reagents were prepared as recommended by their suppliers. 
 
Induction and treatment  
E. faecalis spent medium, the commercially available major cell wall component 
of E. faecalis, LTA, as well as the crude extraction of cell wall were used as induction 
material in experiment.  The fresh bacterial growth medium and cell wash solution, 
distilled phosphate-buffered saline (PBS) were used as negative controls.  Ten milliliters 
of fresh growth medium was added to the cells prior to treatments.  Latently infected 
lymphoid cells (B95-8, DG75 and BL-41) were maintained at densities between 2.5 x 105 
and 3.0 x 105 cells/ml. B95-8, BL41 cells and DG75 cell lines and induction materials 
were incubated for 12hrs or 48 hrs. For inhibition experiments, cells were pre-incubated 
in culture medium supplemented with TLR2 antagonist (TLA2.1) at 20 µg/ml or Bay 11 
at 2uM for 1 h at RT.  These cells were subsequently induced into the lytic cycle by 
exposure to 20 µg/ml LTA (17). The successful re-activation of latent virus was assessed 
via qPCR for virions released into the supernatant and by viral protein expression.   
To determine the effect of EBV on E. faecalis infection,  cell lines with and 
without latent EBV were incubated with E. faecalis at a starting concentration of 103 
CFU/ml for 12 hrs.  Bacterial cells were harvested by centrifugation of the culture at 
8,000 rpm for 15 minutes.  The cell pellets were stored at -80°C for assessment of 
quantities and virulent gene expressions. 
 
Extracellular EBV virion DNA isolation and quantification 
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Cells were removed from the medium by centrifugation at 1,500 x g for 5 min. 
The supernatant was collected and centrifuged again for 30 min at 3,000 rpm. The cell-
free culture medium was filtered through a 0.45-micrometer-pore-size filter distributed 
into Beckman Ultra Clear tubes, and viral particles were pelleted by centrifugation at 
22,000 x g for 2 h at 4°C. The supernatant was removed, and viral pellets were 
resuspended in buffer containing 40 mM Tris-HCl (pH 7), 10 mM NaCl, 6 mM MgCl2, 
and 10 mM CaCl2. RQ1 DNase was added, followed by incubation at 37°C for 1 h to 
eliminate free DNA. DNase was inactivated by adding EDTA to 20 mM and heating to 
80°C for 5 min. Viral DNA was isolated using a High Pure viral nucleic acid kit (Roche, 
Indianapolis, IN).  
Viral DNA within each sample was quantified using quantitative PCR (QPCR) 
with the specific primers targeting W area of EBV, (5'-CCTGGTCATCCTTTGCCA-3' 
and 5'-TGCTTCGTTATAGCCGTAGT-3'), and SYBR Green PCR Kit (Roche).  For 
each sample tested, the QPCR assay was performed with a final volume of 25µl reaction 
mixture, containing 100 ng of DNA.  Amplification conditions were initial 2 min at 50°C 
to eliminate carryover contamination, denaturation at 95°C for 10 min, 40 cycles 
consisting of denaturation at 95°C for 15 s, annealing at 60°C for 1 min., and extension at 
72°C for 30 s, and final extension at 72°C for 7 min.  DNA from uninfected DG75 cells 
and reactions run in the absence of added DNA served as negative controls.  To make 
viral quantities within each sample comparable, β-actin DNA within each sample was 
used as internal control.  β-actin DNA was quantified using QPCR with specific primer 
(5’-GGAACCGCTCATTG CC-3’ and  ’-ACCCACACTGTGCCCATCTA-3’ .  
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Analyses of the data were performed with associated Prism 7000 software (Applied 
Biosystems). The uninduced EBV level was arbitrarily set at 1.  
 
Cell lysis, bacterial lysis and Nucleic acid isolation 
Cells were pellet from treated cell culture via centrifugation at 1,500 x g for 5 
min.  The cell was then resuspended in DPBS and split into two portions, 1/3 was used 
for DNA isolation using DNeasy kit (Qiagen, Carlsbad, CA, USA), 2/3 was used for 
RNA isolation using RNeasy kit (Qiagen) according to the procedure recommended by 
the manufacturer.  
The bacterial cell pellet was resuspended in a lysis buffer consisting of 20mM 
Tris (pH 8.0), 2mM EDTA, 1.2% Triton X-100 in RNase free water supplied with 
Lysozyme (20mg/ml), and incubated at 37 °C for 30 minutes.  The lysate was split into 
two portions, 1/3 was used for DNA isolation using DNeasy kit (Qiagen), 2/3 was used 
for RNA isolation using RNeasy kit (Qiagen) according to the procedure recommended 
by the manufacturer.  
 
cDNA generation  
RNA was reverse transcribed to cDNA using Superscript II Reverse Transcriptase 
(RT) and Random Hexamer pd(N)6 according to the procedure recommended by the 
manufacturer.  For each sample, a no-RT control was used.  Absence of DNA 
contamination in the process was assured by end-point PCR for no-RT control with 
bacterial universal primers   ’- TCCTACGGGAGGCAGCAGT -3’ and  ’- 
GGACTACCAGGGTA TCTAATCCTGTT -3’  (18) designed based on a conserved 
 30 
 
region of 16S rDNA.  The PCR mix (25 µl) contained 1 µl template cDNA, 1 mM 
MgCl2, 0.1 mM concentrations of each deoxynucleoside triphosphate, 0.4 µM 
concentrations of each primer, 0.5 U of Taq Polymerase, and TAQ buffer with final 
concentrations of 10 mM Tris-HCl (pH 8.3) and 10 mM KCl. Amplification conditions 
were initial denaturation at 94°C for 4 min, 40 cycles consisting of denaturation at 94°C 
for 30 s, annealing at 55°C for 30 s., and extension at 72°C for 30 s, and final extension at 
72°C for 7 min..  
 
Assessment of E. faecalis virulent gene expression 
The expression levels of virulent genes in E. faecalis were evaluated using real-
time PCR with the corresponding primers (listed in Table 1), which were designed based 
on the E. faecalis sequences using Primer3, and SYBR Green PCR Kit (Roche).  The 
real-time PCR conditions were set at 50°C for 2 min and 95 °C for 10 min, followed by 
40 cycles at 94°C for 15 s, annealing at 55°C for 30 s.  All analyses were performed in 
triplicates and included the negative control of sterile H2O.   
 
Protein preparation and Western blot 
For extraction of total cellular protein, cells were collected by centrifugation, 
washed once in PBS, resuspended in 200 µl ice cold extraction (RIPA) buffer (50 mM 
Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl 
sulfate [SDS], 1% Na deoxycholate, 25 µg/ml leupeptin, and 50 µl protease inhibitor 
cocktail [Sigma]), passed through a 25-gauge needle, and centrifuged. For nuclear protein 
extraction, cell pellets were washed as described above and resuspended in 500 µl ice 
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cold extraction buffer A (10 mM HEPES [pH 7.9], 1.5 mM MgCl2, 10 mM KCl, 1.0 mM 
dithiothreitol) and centrifuged. Cells were then resuspended in 200 µl buffer A containing 
0.1% NP-40 and 1x complete proteinase inhibitor, incubated on ice for 10 min, and 
centrifuged to pellet nuclei. Nuclear pellets were washed in buffer A, centrifuged, and 
resuspended in 50 µl of extraction buffer C (10 mM HEPES [pH 7.9], 420 mM NaCl, 1.5 
mM MgCl2, 0.2 mM EDTA, 1.0 mM dithiothreitol, 25% glycerol), incubated on ice for 
30 min with occasional vortexing, and centrifuged. Cell lysates were resuspended in SDS 
sample buffer, and 50 to 150 µg of proteins was loaded in lanes for SDS-polyacrylamide 
gel electrophoresis (10% gel was used).  Western blot analysis was performed for the 
detection of proteins expressed in active EBV using antibodies specific for EBV EA-D 
protein following the procedure published previously (13).   The blot was also reacted 
with antibodies to detect β-actin to confirm equal protein loading.  The relative levels of 
expression of each cellular or viral protein were compared by quantitative densitometry.   
 
RESULTS 
Treatment of latent EBV infected cell lines with E. faecalis results in EBV 
reactivation  
The cell wall components containing LTA among others had significant effect on 
the ability of latently infected cells (B958) to release virions into the medium, and 
resulting in a 6-fold increase in viron release.  Compared to treatment with the medium 
alone (Figure 1A), LTA at 20 µg/ml resulted in a 17 fold increase in virus release. 
Interestingly, the spent medium of E. faecalis used in this study was comparable to the 
uninduced negative control and had minimal effect on induction of the EBV lytic cycle.  
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Lymphoma cell line, BL 41 containing EBV, had a 340-fold increase in virion quantity 
post LTA induction (Figure 2B).  The ability of the major cell wall component of E. 
faecalis, LTA, to activate latent EBV infection was further confirmed by the Western blot 
detection of the early lytic antigen EAD (Early Antigen Diffuse) expression.  Upon 
densitometry, it was determined that EAD expression was enhanced greater than 6-fold 
upon E. faecalis LTA treatment (Figure 1B).  Additionally, viral genes from each stage of 
the temporal lytic cycle were assessed.  Compared to uninduced cells, in cells with 12-
hour post E. faecalis LTA treatment, immediate early transcripts encoding for RTA were 
increased 8-fold; early transcripts encoding EAD were increased 90-fold;  and late gene 
transcripts encoded by BcRF1 increased 4x 103-fold (Figure 1C).    
 
TLR2 antagonists and NF-kB inhibitor, Bay 11 diminished E. faecalis induced EBV 
replication.  
E. faecalis LTA -mediated induction of lytic EBV infection was significantly 
reduced by treatment with both the TLR2 antagonist and an NF-kB/Ikb pathway inhibitor, 
Bay 11.  In this set of experiments a 7-fold increase in virion production was detected 
upon E. faecalis LTA treatment.  Pretreatment with the TLR 2.1 antibody resulted in 
diminished virion production to levels comparable to uninduced.  Assessment of TLR2 
antagonist treatment also significantly reduced expression of the EBV lytic protein EAD 
(Figure 1B).  This indicated that E. faecalis activation of latent EBV may occur through 
TLR2 mediated NF-   pathway, but may also involve other undefined mechanisms.  
Similar experiments were performed in BL41 cell line with latent EBV infection.  BL41 
cells treated with LTA demonstrated enhanced virion production that was significantly 
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reduced approximately 7-fold upon treatment with both the TLR2 antagonist, and the NF-
kB/Ikb pathway inhibitor, Bay 11.  However, these levels were not reduced to the level of 
uninduced upon pretreatment with the TLR 2.1 antibody and Bay 11 (Figure 2B),  
 
EBV enhanced the growth and virulence of E. faecalis.   
Co-culture of E. faecalis and lymphoid cells with or without EBV showed that 
more E. faecalis grew in the culture when EBV presented.  The QPCR data are consistent 
with the density data (Figure 3).  When comparing bacterial quantities by qPCR, a 4.7-
fold difference was detected in bacterial load when bacteria were co-cultured with BL 41 
cells containing latent EBV versus bacterial cells cultured with virus negative cells 
(Figure 3B).  Furthermore, the presence of EBV, in co-culture resulted in detection of 
enhanced E. faecalis virulence-associated genes expression.  Two distinct virulent EF 
strains, ER5/1 and ER3/1, were assayed post co-culture with BL 41 cell with or without 
EBV.  Three different virulence-associated genes were assessed for each strain.  For ER 
5/1, v1-Ef0485, an aggregation substance gene, v2-gelE, a gelatinase gene and, v3-ace a 
collagen binding antigen were assessed.  For ER 3/2s   v1-Ef0485, an aggregation 
substance gene, v2-esp, a surface adhesion protein and, v3-ace a collagen binding antigen 
were assessed. For analysis, the co-culture containing BL41 no virus was set to one.  In 
co-cultures containing EBV, 2-3 fold increases were detected in expression of all of the 
virulence-associated genes regardless of E. faecalis strain (Figure 3C).   
 
E. faecalis and EBV increased inflammatory gene expressions  
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Both LTA and crude cell wall extract resulted in an 8- and 7-fold increases, 
respectively, in IL-6 transcript expression as determined by real-time RT PCR (Figure 
4A).   At 12 hours post treatment of B958 cells with E. faecalis LTA, the expression of 
pro-inflammatory genes was assessed.  Enhanced expression of all four genes assayed 
was detected in E. faecalis LTA treated virus containing cells compared to untreated 
B958 cells;  A 38-fold increase in TNF-α mRN , a 20-fold increase in IL-6 mRNA, a 
120-fold increase in IFN-β mRN , and a 60-fold increase in IL-10 mRNA were detected.  
All increases were statistically significant (P < 0.001).  We next directly compared the 
expression of these inflammatory mediators in E. faecalis treated EBV positive and 
negative cell lines.   The expression of the inflammatory mediators was significantly 
higher in the cell line with EBV infection treated with E. faecalis LTA compared to cell 
line without EBV infection treated with E. faecalis LTA; for TNF-α 3  folds higher, IFN-
β 11  folds higher, IL-10 50 folds higher and IL-6 15 folds higher (Figure 4C).   
 
DISCUSSION 
Polymicrobial infections are present throughout the body and play a significant 
role in disease development.  Viral-bacterial synergy in infectious diseases has been 
proposed (1-3).  In this study we investigate the potential for interaction of the Gram-
positive bacterium, E. faecalis and EBV, as both organisms that have been detected in 
severe persistent endodontic infection.  The results from this study support our hypothesis 
that E. faecalis can re-activate latent EBV infection.  The reactivation is most likely via 
TLR2 mediated NF-kB/Ikb pathway, although other yet undefined pathways may be 
involved as well.  The data presented in this study support our hypothesis that EBV may 
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facilitate E. faecalis pathogenesis.  It appears that the interactions of EBV and E. faecalis 
aggregate cellular inflammatory response.   
Previous studies from our group have determined that metabolic end products of 
the Gram-negative anaerobic pathogens, F. nucleatum and P. gingivalis can reactivate 
KSHV lytic replication, resulting in an increase in the release of virions; while metabolic 
end products from Gram-positive organisms, S. aureus and S. mutans, did not result in 
activation of latent KSHV (13).  In this study, metabolic end products from the Gram-
positive bacterium, E. faecalis did not result in activation of the related gamma 
herpesvirus latent EBV.  We demonstrate that E. faecalis LTA engagement of the TLR2 
receptor (17, 19-20) is a potent inducer of EBV reactivation.  Likewise, it has been shown 
that activation of TLR 7/8 results in reactivation of the related herpesvirus, KSHV (21).  
In our study, we demonstrate that E. faecalis LTA mediated reactivation of EBV most 
likely occurs though TLR2 mediated NF-kB/Ikb pathway.  Mechanisms of bacteria 
mediated reactivation are distinct between these two gamma herpesviruses (22).  Previous 
studies suggested cross-talk exists between different TLRs (23-24), some TLRs might 
share similar signal transduction pathways.  Recent studies also determined that 
activation of TLRs may lead to activation of other transcriptional factors in addition to 
NF-kB (25-26).  In our case, inhibition of TLR2 diminished the LTA mediated re-
activation of latent EBV, but not to uninduced levels, suggesting that other pathways 
might be also involved.  The data from different latently infected lymphoid cell lines 
suggests that the magnitude of E. faecalis activation of latent EBV infection and the 
activation pathways might be cell-type specific.  There may be dependence on the types 
and density of cell surface receptors that bind E. faecalis cell wall components.  Future 
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studies are necessary to validate mechanisms and delineate other potential signal 
transduction pathways involved in the process of re-activation. 
Studies have not yet thoroughly investigated the profile and concentration of the 
components in the metabolic end produce and their relation to the effect of re-activation 
of latent herpesviruses.  Some components in the metabolic end products of gram-
positive bacteria might be able to re-activate latent herpesvirus when higher 
concentration used.  Using current experimental conditions, it seems that the effect of 
gram-positive bacteria re-activation of latent herpesvirus is mainly through the interaction 
between bacteria and the host cells.   
In our study, it was shown for the first time that the presence of EBV tended to 
promote both E. faecalis growth and enhances the expression of bacterial virulence 
factors.  The mechanism of the interaction is unclear.   EBV may condition the host cell 
media to facilitate E. faecalis growth.  Alternatively, there may be indirect bacterial viral 
interactions via the cell inflammatory response or changes of local environment, or 
finally direct interaction between EBV and E. faecalis.  It is known that virulence genes 
in E. faecalis including genes encoding enterococcal surface protein (esp), aggregation 
substance, clustered in a special regions of the genome termed pathogenicity island (PAI) 
(27).  Genes responsible for regulation of PAI genes often locate in the same PAI (28).  
Recent study (29) showed AraC-type transcriptional regulators within PAI, which are 
usually functional in carbon metabolism or stress response, contributes to E. faecalis 
pathogenesis. Cellular metabolism is modulated by viral infection, suggesting the 
changes of local environment (30).  There is the potential that metabolic products 
expressed in EBV infected cell culture supernatants might promote E. faecalis growth 
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and virulence.  The effect of EBV on E. faecalis might attribute to inflammatory factors.  
It is known that EBV can increase cellular IL-10 secretion and expresses a viral homolog, 
vIL-10 (31).  Interestingly, previous study has demonstrated that hIL-1β, si nificantly 
increased Staphylococcus aureus virulence (32).  The mechanism by which hIL-1β e erts 
direct effects on S. aureus gene expression is not clear.  However, the study showed the 
genes from the S. aureus PAI were modulated upon exposed to hIL-1β.   here is a 
possibility that the increased IL-10 level of IL-10 or vIL-10 has direct effect on E. 
faecalis, increasing its virulence-associated gene expression levels.  Alternatively, the 
EBV virions may interact directly with the bacteria.  There is a precedent for this in a 
study that suggested a direct interaction between influenza A virus and the capsule of the 
bacterium N. meningitidis facilitated bacterial adhesion to cultured epithelial cells 
enhancing bacterial virulence (33).  More research is warranted to 1) confirm that the 
phenomenon is not bacterial stain or species dependent; and 2) whether such effect is host 
cell –mediated or metabolic product related. 
The phenomenon of viral bacteria synergy, particularly in respiratory disease, has 
been documented since early last century (34).  In our study, an enhanced inflammatory 
response was observed when both viral and bacterial pathogens were co-present, 
consistent with previous studies on viral bacterial synergy in respiratory disease (35) .  
The release of exogenous agents (e.g. bacterial and viral products) and the subsequent 
induction of endogenous mediators (e.g. cytokines and chemokines) during the 
inflammatory response, contribute to the viral bacterial synergy (35).  The various 
inflammatory factors may interact with each other, may regulate viral- bacterial 
virulence, or modulate host cellular inflammatory responses.   
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The mechanism by which herpesviruses bacteria interact with each other has been 
proposed in previous literature (3).  Base on our data in this study and previous literature, 
we proposed the model of hepersviral-bacterial synergy (Figure 5). Briefly, bacteria 
infecting the healthy pulp result in activation of latent virus within immune cells 
presented in the pulp.  The inflammation caused by bacteria infection may help recruit 
inflammatory cells which potentially harbor latent viruses.  The presence of the bacteria 
and their associated components reactivates the virus within these cells resulting in viral 
replication, which influences the inflammatory milieu subsequently promoting disease. 
In summary, the data presented in this study demonstrated interactions between E. 
faecalis and EBV, and suggested that there is an additive effect between E. faecalis and 
EBV with regard to their contributions to the proinflammatory process.  More studies are 
needed to investigate the mechanisms of these interactions.  
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Table 1  Primers sequences for real-time PCR detection of selected  
             virulent genes expression in E. faecalis 
 
Virulent factors Gene  rimer  equences   ’--3’  
  Forward Reverse 
Aggregation 
Substance ef0485 GTGATTGGGACGCTGTAGGT GCGCACTAGATACAGGCACA 
Surface Adhesin  esp TTTAGCAATTGAGCGACGTG CGATTTTATCCGCTGCTTTC 
Gelatinase  gel GGGGCAATACAGGGAAAAAT TCCTTCCCCAGTTTCCTTTT 
Collagen 
binding antigen ace 
ATGGCTACCACGAAAAATC ATTCGGTTGCGAACTATTGG 
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Figure legends 
Figure 1. Treatment of B958 cells with E. faecalis LTA results in EBV reactivation 
(A). E. faecalis induces EBV virion release.  The levels of EBV virion after the cells 
with latent EBV infection (B958) treated with spent media and cell wall components of 
E. faecalis were quantified as described in Material and Methods.  Fold increases were 
calculated by comparison of the EBV virion quantity from cell culture treated with 
inducers over uninduced culture (the cell without treatment).  The virion level was 
normali ed usin  cell numbers indicated by cellular β-actin levels.  (B). Increased viral 
protein (EA-D) expression induced by cell E. faecalis LTA was inhibitable with 
TLR2 antagonist.  B958 cells were treated with E. faecalis LTA, E. faecalis LTA plus 
TLR2 antagonist. Cellular protein was isolated and immunoblotted for EBV EA-D and β-
actin as described in Materials and Methods section.  (C). Increased viral gene 
expression was induced by E. faecalis LTA.  Viral genes expression levels were 
assessed post 12 hrs treatment of E. faecalis LTA compared to the one without treatment 
(uninduced).  RNA was isolated, cDNA was generated and real-time PCR was performed 
as described in Materials and Methods section.  The viral gene expression levels within 
uninduced samples were set as 1.  The difference was expressed in fold.  Statistically 
significant (P<0.05). 
Figure 2. TLR2 antagonist and Bay 11 decrease E. faecalis induced EBV replication. 
The latent EBV infected cell cultures were pretreated with TLR2 antagonist or Bay 11 
and then treated with E. faecalis LTAfor 1  hrs.   he virion and β -actin levels were 
quantified using QPCR.   he virion levels were normali ed usin  cellular β-actin levels. 
 41 
 
Shown data were the mean of fold increased of virion compared to the one without LTA 
treatment (uninduced).  LTA, E. faecalis LTA treatment only; ihTLR2+LTA, cell treated 
with TLR2 antagonist for 1hr and then treated with E. faecalis LTA;  Bay11+LTA, cell 
treated with Bay11 for 1hr and then treated with E. faecalis LTA. (A) B958 cell line; (B) 
BL41 cell line with latent EBV infection.  Statistically significant (P<0.05).  
Figure 3 EBV enhanced the growth and virulence of E. faecalis.  (A) The bacterial 
cell density after incubation with cell lines (BL41) with or without latent EBV. 
Overnight culture of E. faecalis was diluted to 1:100 and then incubated with BL-41 w/ 
or w/o EBV for 12 hrs.  Cell density was determined by measuring the optical density at 
600nm.  (B) The bacterial quantities after incubation with cell lines (BL41) with or 
without latent EBV. The bacterial DNA from the culture treated as above were isolated 
and quantified using   CR.  acterial quantities were normali ed usin  β-actin.  (C) The 
increases of virulent gene expression levels in E. feacalis with presence of EBV 
compared to the one without presence of EBV.  Clinical isolates of E. feacalis were 
incubated with cell line (BL41) with or without latent EBV for 12 hrs.  The gene 
expression level was normalized using bacterial cell 16S rRNA.  The expression levels of 
virulent genes and 16S rRNA were quantified using real-time PCR. The expression levels 
of virulent genes within individual E. faecalis strain co-cultured with BL41 without latent 
EBV infection were set as 1 (BL41-EBV+E. faecalis).  V1: Ef0485; V2: gelE for E. 
faecalis 5/1 or esp for E. faecalis 3/2s; V3: ace.   Statistically significant (P<0.05). 
Figure 4 E. faecalis and EBV increased inflammatory gene expressions.  (A) The IL-
6 gene expression in B958 cell line treated with E. faecalis LTA.  The B958 cell line 
was treated with E. facealis spent medium, crude cell wall extractions and LTA for 48 
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hrs.  Cellular RNA was isolated and IL-6 gene expression levels were evaluated using 
real-time RT-PCR.  The expression level within uninduced sample was set as 1.  The 
difference was expressed in folds increase of IL-6 gene expression levels in B958 cells 
with treatments compared to the one without treatment (uninduced).  Similar results were 
obtained for both E. facealis strains.  (B). The inflammatory genes expressions in B958 
cell line treated with E. faecalis LTA.  B958 cells were treated with E. facealis LTA for 
12 hrs.  Cellular RNA was isolated.  TNF-α, IFN-β, I -10 and IL-6 gene expression 
levels were evaluated using real-time RT-PCR.  The expression level within uninduced 
sample was set as 1.  The difference was expressed in folds increase of gene expression 
levels in B958 cells with treatments compared to the one without treatment (uninduced).  
Similar results were obtained for both E. facealis strains.  (C). The inflammatory genes 
expressions in cells with and without latent EBV infection after treated with E. 
faecalis LTA.  Cells with latent EBV infection (B958) and without latent EBV infection 
(DG-75) cells were treated with E. facealis LTA for 12 hrs.  Cellular RNA was isolated.  
TNF-α, IFN-β, I -10 and IL-6 gene expression levels were evaluated using real-time RT-
PCR.  The expression level within uninduced sample was set as 1.  The difference was 
expressed in folds increase of gene expression levels in cells with treatments compared to 
the one without treatment (uninduced).  Similar results were obtained for both E. facealis 
strains.   Statistically significant (P<0.05). 
Figure 5. Hypothetical model of viral involvement in endodontic disease progression 
via viral-bacterial interaction.  Once the healthy pulp becomes infected with bacteria, 
this results in the recruitment of inflammatory cells which potentially harbor latent 
viruses.  The presence of the bacteria and their associated components reactivates the 
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virus within these cells resulting in viral replication, which influences the inflammatory 
milieu subsequently promoting disease. 
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ABSTRACT 
Introduction: We have previously shown in vitro that bacterial metabolites 
enhance Epstein-Barr virus (EBV) replication.  In this study, we hypothesized that 
individuals with symptomatic endodontic disease would have elevated bacterial/viral 
replication and inflammation compared to that of asymptomatic individuals.  
Methods: Twenty pulp tissue samples were collected from patients diagnosed 
with irreversible pulpits, 10 with symptoms of self-reported severe pain (>7 on 10-point 
pain scale, Symptomatic) and 10 without self-reported pain (Asymptomatic), 
respectively.  As controls, ten pulp tissue samples were collected from extracted healthy 
3rd molars, which had no fracture, caries, or periodontal disease.  Additionally, two 
periapical tissue samples were collected during apicoectomy from patients with persistent 
periapical infection after root canal treatment.  Total DNA and RNA were extracted from 
pulp tissue using DNeasy and RNeasy kit (Qiagen), respectively. Quantification of  total 
bacteria, Streptococcus sp., Lactobacillus sp., Fusobacterium sp., Actinomyces sp., E. 
faecalis, EBV and Human Cytomegalovirus (HCMV) were assessed using quantitative 
PCR (qPCR) for consensus or organism specific DNA.  Total bacterial RNA was used to 
indicate transcriptional activity and was evaluated using quantitative reverse-transcriptase 
PCR (RT-PCR).  The expression of inflammatory genes including IL-6, IL-10, TNF-α, 
TNF-β and IFN-β was evaluated using quantitative reverse-transcriptase PCR.   
Results: A greater than 5-fold increase was detected in bacterial DNA levels from 
pulp tissue of symptomatic patients compared to controls (P=0.004).  These differences 
were not detected between asymptomatic patients and the control (P= 0.275).  Likewise, 
total bacterial activity (RNA) was 5-fold higher in symptomatic patients than the 
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asymptomatic (P=0.027).  Lactobacillus sp., Fusobacterium sp. and Actinomyces sp. 
were present in inflamed pulp tissue, but not in healthy pulp tissue.  Among the samples 
with Streptococcus sp., asymptomatic pulp tissues had 30 fold higher levels, and 
symptomatic pulp tissues had  5 folds higher levels detected compared to controls 
(P=0.001, P=0.003 respectively).   Interestingly, while EBV was widely detected, CMV 
was detected only in periapical tissues.  Greater than a 30-fold increase in EBV DNA was 
detected in pulp tissue from symptomatic individuals compared to controls (P<0.001).   
Further, a 30-fold difference was shown in EBV detection in pulp tissue from 
symptomatic compared to asymptomatic (P=0.028) patients. The quantity of EBV in the 
pulp tissue from asymptomatic patients was comparable to the control (P=0.403).   Real-
time RT-PCR analysis of inflammatory gene expression in pulp tissues detected 
expression in disease but not within healthy controls.  The IL-6 gene was expressed at 
levels 11-fold higher in symptomatic pulp than in asymptomatic pulp (P=0.026).  
Regression analysis indicated that inflammatory gene expression levels were associated 
with bacterial transcription and with EBV viral load.  
Conclusion: The results suggest a significant association between bacteria, EBV 
and inflammation in symptomatic disease within the pulp tissue.  CMV is more tightly 
associated with chronic infection than acute infection.  These results support a paradigm 
shift in which elevated bacterial/viral replication and inflammation are associated with 
endodontic infection.  
 Keywords: EBV, CMV, bacteria, inflamed pulp tissue, quantitative-PCR 
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INTRODUCTION 
Endodontic disease is a polymicrobial, multistage inflammatory response initiated 
by the migration of opportunistic microorganisms from the oral cavity.  This leads to an 
influx of inflammatory cells, resulting in pulpitis and periapical periodontitis.  The 
significance of bacteria in the progression and perpetuation of pulpal and periradicular 
inflammatory diseases is indisputable (1-2).  Endodontic infections involve multiple 
bacteria.  Two hundred different species have been identified within infected root canals, 
usually in combinations of 4-7 species (spp.) per canal (3-5).  Of these, however, between 
15 to 30 bacterial species have been most frequently detected in infected root canals (4-
6).  Among them, Fusobacterium nucleatum, Streptococcus spp., Lactobacillus spp. and 
Actinomyces spp. are the most commonly detected bacteria (4-6).  A positive correlation 
exists between the number of bacteria in an infected root canal and the size of 
periradicular radiolucencies (7).  There tends to be an association between different 
bacterial species and different clinical signs and symptoms, however, this association is 
not conclusive (4, 8).  Whether other pathogens involved in endodontic pathogenic 
processes could affect the above mentioned association is not clear. 
Once bacteria and/or their by-products invade pulp tissue, non-specific 
inflammatory reactions and immunologic responses are excited.  Bacteria and their by-
products interact with immune cells via toll-like receptors (TLRs) (9). Binding of 
bacterial adjuvant to these receptors activates Nuclear Factor- B (NF B), a central 
signaling pathway that leads to transcription of multiple proinflammatory molecules (10).  
All of these inflammatory factors may contribute to disease progression.   
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During the past decade, viruses have emerged as putative periapical pathogens, 
particularly Epstein Barr Virus (EBV) and human Cytomegalovirus (CMV) (11-14).  
EBV is present more frequently in endodontic pathosis than in healthy controls (8), thus 
may play a role in the development of symptomatic periapical lesions (12-13).  EBV and 
CMV belong to the herpes virus family, and 60-100% of adults are carriers of these 
viruses (15).  Herpes viruses may establish latency or a productive (lytic) state of 
replication. In the viral productive cycle, the herpes virus genome is amplified 100- to 
1000-fold by the viral replication machinery, producing a significant increase of virions.  
(16).  EBV infects B-lymphocytes and establishes latency (16), while CMV infects 
monocytes/macrophages, T-lymphocytes, ductal epithelial cells of salivary glands, 
endothelial cells, fibroblasts and polymorphonuclear leukocytes, and establishes latent 
infection mainly in cells of the myeloid lineage (16).  Herpes virus infections induce 
strong antiviral innate and adaptive immune responses.  They evade the immune system 
through a complicated multifactorial mechanism either via NF-    pathway  undefined 
mechanism (16).  Herpes viruses interfere with innate and adaptive cellular and humoral 
immune response by affecting cytokine production, the activation and silencing of natural 
killer cells, down-modulating antigen presentation in the major histocompatibility 
complex class I and II pathways, and impairing apoptosis (17).  Cytokines produced in 
viral infection can significantly modulate the inflammatory response and include 
interleukin (IL)-1β, I -1 receptor antagonist (IL-1Ra), IL-6, IL-8, IL-18, TNF-α, INF-
α β, INF-  (17).  
Few studies have investigated the role of herpes virus in endodontic diseases (8, 
12-13, 18), particularly in irreversible pulpitis.  The limitations of these studies was that 
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bacteria was not viewed as a  potential confounding factor and effect modifiers were not 
taken into consideration when establishing the associatoin between virus and endodontic 
disease.  In this exploratory study, we investigated the levels and activity of total bacteria 
and herpes viruses (EBV and CMV) within both inflamed and healthy pulp tissue.  
Previous literature has been shown that IL-1 activity is greater in symptomatic than in 
asymptomatic pulps (19).  In this study, we hypothesized that inflammatory mediators 
would be present at higher levels in symptomatic pulp tissue than the asymptomatic; and 
that quantitatively lower inflammatory mediators correlate with lower bacterial and viral 
levels present within the pulp and with diminished symptoms of pain.   
 
MATERIALS AND METHODS 
Study design and Collection of Specimens 
A case-control study was performed (IRB#08-0229, UNC). One case group was 
defined as patients diagnosed clinically with irreversible pulpitis and seeking endodontic 
treatment.  This case group was further divided into 2 different subgroups, patients with 
self-reported symptom of severe pain (>7 on 10 point pain scale) (Symptomatic group) 
and patients without symptoms of pain (asymptomatic, <1 on 10 point pain scale) 
(Asymptomatic group).  All patients diagnosed with irreversible pulpitis had caries pulpal 
exposure in the study.  Another case group consisted of patients who had previous root 
canal treatment and persistent periapical infection, and thus apicoectomy was indicated 
for treatment (Chronic Periapical group).  Two patients recruited in this group had no 
symptoms of pain or swelling.  The control group consisted of patients with healthy pulp 
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tissue (extracted third molars), and were matched with cases for age.  Teeth with caries, 
prior restoration, or cracking were not eligible.  Subjects over the age of 12 seeking 
endodontic treatment for irreversible pulpitis or have 3rd molar extracted were eligible for 
inclusion in the study.    The age of all subjects recruited in the study was from 25 to 45 
years old.  The gender of the subjects in symptomatic, asymptomatic and control groups 
were comparable.  Exclusion criteria included: 1) patients that were immune 
compromised, had diabetes or were currently taking antibiotics or other medications 
potentially influencing the immune response; 2) teeth with periodontal disease (probing 
depth >4mm, with periodontal bone loss) or vertical root fracture; and 3) immature teeth 
with open apices. 
Specimens used in the study were collected from patients seeking dental care at 
the University of North Carolina, School of Dentistry.  Selected teeth were rubber-dam 
isolated and disinfected with 2% Chlorohexidine.  The teeth were disinfected with 2% 
Chlorohexidine again after caries removal but prior to pulpal exposure. The access was 
then performed using a sterilized round bur.  For the control group, the extracted tooth 
was placed in 10% formalin.  Then the tooth was disinfected with 2% Chlorohexidine 
and accessed using a sterilized round bur on the same day of extraction.  The pulpal 
tissue was subsequently extirpated using sterilized barbed broach.  The pulp tissue was 
then stored in RNA-later (Qiagen, Carlsbad, CA, USA) at -80 °C until further processing.  
 
Extraction of Nucleic Acids from Specimens, cDNA Generation  
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All tissue specimens were minced with sterile scalpels.  Approximately 1/3 of 
each total specimen was used for DNA isolation using a DNeasy tissue kit (Qiagen), and 
2/3 was used for RNA isolation using RNeasy kit (Qiagen) according to manufacturer 
instructions. 
RNA was then reverse transcribed to cDNA using Superscript II Reverse 
Transcriptase (RT,) and Random Hexamer pd(N)6 according to  manufacturer 
instructions (Invitrogen, Carlsbad, CA, USA).  For each sample, a no-RT control was 
generated.  The absence of bacterial DNA contamination in the process was assured by 
end-point PCR of the  no-RT control using bacterial universal primers   ’- 
TCCTACGGGAGGCAGCAGT -3’ and  ’- GGACTACCAGGGTA TCTAATCCTGTT 
-3’  desi ned based on a conservative region of 16S rDNA.  The PCR mix (25 µl) 
contained 1 µl template cDNA, 1 mM MgCl2, 0.1 mM concentration of each 
deoxynucleoside triphosphate, 0.4 µM concentration of each primer, 0.5 U of Taq 
Polymerase, and TAQ buffer with final concentrations of 10 mM Tris-HCl (pH 8.3) and 
10 mM KCl. Amplification conditions were as follows initial denaturation at 94°C for 4 
min, 40 cycles consisting of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, 
extension at 72°C for 30 s, and final extension at 72°C for 7 min.  
 
Assessment of Bacterial and Viral DNA loads of Bacterial RNA load  and of 
Inflammatory Gene Expression Levels 
The quantities of EBV, HCMV, total bacteria, Streptococcus sp., Lactobacillus 
sp., Actinomyces sp., and Fusobacterium sp. were evaluated using quantitative PCR 
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(qPCR) with 1µl DNA isolated from the sample as the template, the corresponding 
primers (listed in Table 1) and SYBR Green PCR Kit (Roche, Indianapolis, IN, USA). 
The real-time QPCR conditions were set at 50°C for 2 min and 95 °C for 10 min, 
followed by 40 cycles at 94°C for 15 s, finished by annealing at 55°C for 30 s.   The total 
bacterial transcriptional activity was quantified using qPCR with 1µl cDNA generated as 
the template.  The expression levels of inflammatory genes, IL-6, IL-10, TNF-α,  NF-β, 
IFN- β, were evaluated using real-time PCR with the corresponding primers (listed in 
Table 1) and SYBR Green PCR Kit (Roche).  The QPCR conditions were as described 
above.   All analysis was performed in triplicate and included the negative control 
consisted of sterile H2O.   
 
Statistical Analysis 
The differences between bacterial and viral loads and inflammatory gene 
expression levels between groups were analyzed using ANOVA for multi-groups 
comparison and t-test for 2 group comparison.  Regression analysis was performed to 
investigate the association between the inflammatory gene expression levels and bacterial 
quantity, activity and viral quantities (SPSS 17.0, Chicago, IL). 
 
RESULTS 
The bacterial profiles within the pulp tissue were unique in acute or chronic infected 
pulp tissue as compared to controls.   
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The prevalence of total bacteria, Streptococcus sp., Lactobacillus sp., 
Actinomyces sp., Fusobacterium sp. and E. faecalis within the tissue samples from 4 
groups in the study were listed in Table 2.  No E. faecalis was detected in the pulp tissue 
samples from all three groups (Table 2) but was consistently detected in 2/2 periapical 
tissue samples.  In control group, among 5 bacterial species investigated, only 
Streptococcus sp., was detected in 9 out of 10 samples; the other 4 were below the level 
of detection (Table 2).  Alternatively, all 5 bacterial species were detected in the pulp 
tissue from both symptomatic and asymptomatic patients and in periapical tissue.   
However, Fusobacterium sp. and Lactobacillus sp. presented in 30% and 50% samples 
from asymptomatic patients, respectively; compared to 100% in symptomatic patients 
(Table 2).   In periapical tissue, with the exception of Actinomyces sp. that presented in 
half of the samples, all other 4 bacterial species presented 100% (Table 2).  The total 
bacterial DNA levels in pulp tissue were statistically significantly higher (5-fold) in pulp 
tissue from symptomatic patients than the control (P=0.004) but not the asymptomatic 
patients (P= 0.275) (Figure 1A).  No statistical differences regarding total bacterial DNA 
in pulp tissue were detected between asymptomatic patients and control (P=0.407) either 
(Figure 1A).  Among the samples with Streptococcus sp., more bacteria was detected in 
diseased pulp from asymptomatic (30-fold) and symptomatic (5-fold) patients than in the 
controls, respectively (P=0.001, P=0.003 respectively) (Figure 1B).  Further, statistically 
significant higher levels of Streptococcus sp. DNA was present in pulp tissue from 
asymptomatic compared symptomatic patients (P=0.048) (Figure 1B).  No statistical 
significant differences between symptomatic and asymptomatic groups were found in 
Lactobacillus sp. DNA load (P=0.822), Actinomyces sp. DNA load (P=0.757), or 
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Fusobacterium sp. DNA load (P=0.403).   
The total bacterial RNA analysis showed 5- fold more bacterial transcripts present 
in pulp tissue from symptomatic patients than the asymptomatic patients (P=0.027) 
(Figure 1C), even though there was no statistical difference in total bacterial DNA levels 
between two groups (P=0.407) (Figure 1A). Analysis of bacterial mRNA determined that 
total bacteria mRNA in samples from the control group was below the level of detection, 
indicating the bacterial activity was minimal if indeed present.   
 
Significantly higher loads of EBV were detected within the pulp tissue from patients 
diagnosed with irreversible pulpitis and symptoms of severe pain. 
In this study, HCMV was not detected in symptomatic, asymptomatic or controls 
while EBV was detected in each of these groups (Table 2).  However, HCMV was 
detected in two samples collected from periapical lesions during apicoectomy (Table 2).    
Greater than 30-fold higher EBV levels were detected in pulp tissue from symptomatic 
individuals compared to the controls (P<0.001).   In addition, statistically higher levels of 
EBV were detected in pulp tissue from symptomatic than asymptomatic (P=0.028) 
patients (Figure 2).   Interestingly, EBV levels in the pulp tissue from asymptomatic 
patients were comparable to controls (P=0.403) (Figure 2).     
 
Inflammatory gene expressions levels were significantly higher in symptomatic 
individuals  
Gene expression of TNF-α,  NF-β, I -6, IL-10 and IFN-β was consistently 
detected in the symptomatic pulp tissue, but not in the controls (Figure 3A).   Expression 
 64 
 
levels within the asymptomatic group were varied (data not shown).   There was a 
significant positive correlation between the TNF-α,  NF-β, I -6 and IL-10 (Table 3).  
Gene expression of IFN-β was negatively correlated with that of TNF-α,  NF-β, I -6 and 
IL-10 (Table 3). Because of its high correlation with inflammatory genes expression, only 
IL-6 was selected to perform further analysis.  The IL-6 gene was expressed at levels 11-
fold higher in pulp tissue from symptomatic patients than in asymptomatic patients 
(P=0.026) (Figure 3B).  Furthermore, regression analysis showed that expression of IL-6 
was significantly associated with bacterial transcriptional activity (P= 0.045) and EBV 
viral load (P= 0.025) (Figure 4).  Even after adjusting for bacterial gene expression, IL-6 
expression was still significantly associated with EBV viral load (P=0.022), indicating 
that EBV contributes to the pulp’s inflammatory response.  After interaction between 
EBV viral load and total bacterial transcriptional activity was introduced to the regression 
model, IL-6 expression levels were significantly associated with EBV viral load 
(P=0.019), total bacterial transcriptional activities (P= 0.015) and their interaction was 
significant (P=0.014).  The mean (Standard deviation) age were 31.4 (5.74), 33.2 (7.16) 
and 33.1 (4.75) for Symptomatic, Asymptomatic and Control group, respectively.  There 
were 6 male, 5 male and 5 male in Symptomatic, Asymptomatic and Control group, 
respectively.  There were not statistically significant differences in both age and gender 
among groups (P>0.05).  Therefore, the age and gender were not included in the 
regression analysis.  
 
DISCUSSION 
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In this study, we sought to determine the role that bacterial and viral pathogenesis 
play in the progression of endodontic disease.  This study determined that 1) there was a 
significantly higher amount of total bacteria within the pulp tissue from the subjects s 
diagnosed with irreversible pulpitis than in the control groups; 2) that total bacterial 
transcriptional activity was statistically significantly higher in symptomatic pulp tissue 
than the asymptomatic; 3)  that EBV but not CMV was detected in the pulp tissue from 
both case and control groups,; 4) that significantly higher EBV loads were detected in 
symptomatic pulp tissue compared to  asymptomatic and the control groups; 5) that  IL-6 
expression is significantly higher in symptomatic pulp than in asymptomatic pulp; and 6) 
that IL-6 expression levels were significantly associated with both  bacterial transcription 
and higher EBV viral load.  The results from this study support our hypothesis that 
inflammatory mediators enjoy higher expression in symptomatic pulp, which might be 
associated with higher bacteria activity and EBV loads.    
In this study, we used the pulp tissue from extracted 3rd molar as the control.  All 
these 3rd molars were extracted due to mal-position or orthodontic needs. All these teeth 
were completely formed with closed apex.  The pulps from these teeth should be the 
same as the pulp tissue from other healthy tooth.   However, all these 3rd molars were 
extracted prior to have pulp tissue extirpated.  The nucleic acid in these teeth has larger 
chances to be damaged. The teeth were preserved in RNA- later solution and accessed 
almost immediately after extraction (within 2 hours of extraction) to preserve nucleic acid 
and make it as much comparable to case groups as possible.   
 In this study, we employed the qPCR technique to estimate bacterial quantities.  
However, PCR detects all active, inactive and dead cells.  The major limitation of using 
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quantification of DNA as an estimate of total bacterial cell numbers in this case is that it 
cannot differentiate between living and dead cells.   Bacteria might exist in three natural 
status: living/active, dormant/inactive and dead.  Determination of whether a bacterial 
cell is active or inactive has been a controversial issue during the last two decades (20-
21).  Three methods have been used to assess metabolic activity: 1) measurement of the 
incorporation of radioactive-labeled metabolic precursors, such as thymidine or leucine 
(22); 2) use of a redox-sensitive compound that fluoresces when reduced by an active 
electron transport system (23) and 3) using the amount of nucleic acids, particularly RNA 
within a cell as a proxy for metabolic activity (24).  As the radioactive-labeled precursors 
and redox-sensitive compound cannot be applied in-vivo, detection of total amount of 
ribonucleic acid is the only in-vivo option.  In this study, the total bacterial DNA from 
both living and dead bacterial cells was used to estimate the total number of bacteria. 
However, in order to reflect bacteria that were transcriptional active within the pulp 
tissue, quantitative RT-PCR (q-RT-PCR) to obtain the total amount of bacterial mRNA.  
The results showed more total bacterial RNA was detected in symptomatic than 
asymptomatic pulp, despite the lack of difference in total bacterial DNA levels.  This 
suggests that bacteria in symptomatic pulp are more metabolically active than in 
asymptomatic pulp tissue. 
Distinct bacterial profiles were detected within the groups that were studied.  
Bacteria was ubiquitous, and was detected in symptomatic, asymptomatic and in 100% of 
the control subjects.  Streptococcus sp. Was detected in 90% of the controls.  This is most 
likely due to the salivary bacterial contamination during the sampling process.  
Streptococcus sp. is relatively more prevalent in saliva than other bacteria (Lactobacillus 
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sp., Fusobacterium sp., Actinomyces sp. and E. faecalis) selected in this study, which 
might explain why Streptococcus sp. rather than other selected bacteria was detected in 
majority of the controls (REF).  In addition, mRNA analysis showed the total bacterial 
mRNA level was below the level of detection for all samples in control group, suggesting 
that the contaminating bacteria are not transcriptional active.   
In this study, we did not detect E. faecalis in any samples, consistent with 
previous literature (25), confirming that E. faecalis is most likely not associated with 
primary endodontic infection.  It is not surprising that Streptococci sp. was detected in all 
samples.  Previous literature has shown that Streptococci sp. is one of the most common 
species in the root canal system in both primary (26) and permanent teeth (27).  
Interestingly, more Streptococci sp. was detected in asymptomatic pulp than in 
symptomatic pulp.  Previous studies have determined that the presence of endotoxin is 
associated with pulpal pain and inflammation (28).   Streptococci sp. is not a potent 
endotoxin producer, which might partially explain why it is associated with 
asymptomatic disease.    Fusobacterium sp. was more prevalent in symptomatic pulp than 
asymptomatic pulp, consistent a previous  in vitro study that showed that fusobacterial 
LPS up-regulated the secretion of the inflammatory cytokines IL-6, TNF-a by 
macrophage-like cells (29).  Interestingly, total bacterial loads, EBV loads, and individual 
bacterial loads were more variable in asymptomatic pulp than in symptomatic pulp.  This 
may partially explain why there were no statistically significant differences in 
Fusobacterium sp, Actinomyces sp. and Lactobacillus sp. between symptomatic and 
asymptomatic pulp tissue.  Further study with larger sample size is warranted to draw a 
more definitive conclusion.   
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In this study, we determined that EBV loads were significantly higher in 
symptomatic pulp than asymptomatic pulp.  The results showed, for the first time, that 
within endodontic disease a expression of the pro-inflammatory gene IL-6 was associated 
with EBV viral load even after adjusting bacterial activity. Importantly, these data 
suggest that EBV contributes to pulpal inflammation, and subsequently to patients’ 
symptoms.  In this study, EBV was detected in the pulp tissue from both case and control 
groups, but not CMV.  The results appear to be slightly different from the study by Li et. 
al. (8), which also employed PCR to detect EBV.  They detected EBV in 43.9% samples 
of the endodontic diseases, 0% in healthy control (extracted teeth).  However, the 
different primer sets may have different detection sensitivity.  The primers of qPCR for 
the detection of EBV was designed based on the sequence of WD repeats of EBV gene, 
which, because of the targeting of the repeats,  may be more sensitive than the primers 
used in other literature (8).  Interestingly, we also detected EBV in the control group.  As 
EBV is latent within lymphocytes of the peripheral circulation, we may have detected 
lymphocytes trafficking through the pulp tissue.  
Higher bacterial quantity and activity, along with the higher load of EBV 
contributed to the higher inflammatory activity in the pulp tissue.  These result indicated 
inflammation activity is higher in symptomatic patients than asymptomatic patients.  
Various pro-inflammatory gene expression levels were assessed.  Significant positive 
correlation between the TNF-α,  NF-β, I -6 and IL-10 were observed.  It was shown that 
the gene expression of IFN--β was negatively correlated with that of TNF-α,  NF-β, I -6 
and IL-10.  The inflammatory response is regulated by a network of regulatory cytokines 
produced by Th1- and Th2-type lymphocytes along with other chemotactic molecules 
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(30). IFN--β belongs to the Th1 cytokine produced by Th1-type lymphocytes.  IFN--β is 
important for immunity to certain viruses, bacteria, fungi, and parasites.  The outgrowth 
of EBV-infected B-cells is first controlled by IFN--β   (31). A previous study had shown 
that endodontic pathogens, such as Fusobacterium sp., did not induce much production of 
IFN--β (32).  Collectively, it suggests the high expression of IFN--β might be due to 
acute EBV infection within the pulp tissue.  
In conclusion, this study, for the first time, showed the possible association 
between inflammatory activity within the pulpal tissue during irreversible pulpitis and 
bacterial activity and EBV loads.  Further study is warranted to investigate the 
mechanism and draw a more definitive conclusion.   
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Table 1 Primers sequences for QPCR quantification of selected bacterial species 
Bacterial species Primer name  equences   ’--3’  Reference 
Total bacteria U16S1020F TTAAACTCAAAGGAATTGACGG Sedgley et.al., 2006 
 U16S1190R CTCACGRCACGAGCTGACGAC  
Fusobacterium sp. FusoF AAGCGCGTCTAGGTGGTTATGT Martin et.al., 2002 
 FusoR TGTAGTTCCGCTTACCTCTCCAG  
Streptococcus sp. StrepF AGATGGACCTGCGTTGT Rudney et al., 2003 
 StrepR GCTGCCTCCCGTAGGAGTCT  
Lactobacilli sp. LactoF TGGAAACAGRTGCTAATACCG Byun et.al., 2004 
 LactoR GTCCATTGTGGAAGATTCCC  
Actinomyces sp. ActF GGCKTGCGGTGGGTACGGGC Xia, 2004 
 Uni341 CTGCTGCCTCCCGTAGG Paster, 1998 
E. faecalis E16S72F CCGAGTGCTTGCACTCAATTGG Sedgley et.al., 2006 
 E16S210R CTCTTATGCCATGCGGCATAAAC  
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Table 2.  Prevalence of selected bacteria and herpesviruse within specimens  
 
Twenty inflamed pulp tissue samples were collected from patients diagnosed with 
irreversible pulpits, 10 with symptom of severe self-reported pain (>7 on 10-point scale 
of pain) and 10 without symptom of pain. Two periapical tissue samples were collected 
during apicoectomy from two asymptomatic patients with persistent periapical infection.  
Ten healthy pulp tissues were collected from extracted 3rd molars.  Total DNA was 
extracted from pulp tissue using DNeasy kit (Qiagen).  The quantities of total bacteria, 
Streptococcus sp., Lactobacillus sp., Fusobacterium sp., Actinomyces sp., E. faecalis, 
EBV and HCMV were assessed using quantitative PCR (qPCR).  Shown in table was the 
number of samples with the presence of bacteria as the nominator, the total number of 
samples as the denominator. * Total number of samples. + indicate the level of quantities 
of bacterial or virus can be detected; ++ indicate more than 10 fold than +; +++ indicates 
more than 50 fold than +; ++++ indicates more than 100 fold than+. 
 
 Symptomatic 
(10*)  
Asymptomatic 
(10*)  
Periapical  
(2*) 
Control 
(10*)  
Total Bacteria 10/10  (+++) 10/10 (++) 2/2 (+) 10/10 (++) 
Streptococcus sp.  10/10 (+++) 10/10 (++++) 2/2 (++) 9/10 (++) 
Lactobacillus sp.  10/10(+++) 5/10 (+++) 0/2 0/10 
Actinomyces sp. 10/10(++) 10/10 (+++) 1/2 (++) 0/10 
Fusobacterium sp.  10/10(+++) 3/10 (++) 2/2 (+) 0/10 
E. faecalis  0/10 0/10 2/2 (++) 0/10 
EBV 10/10(+++)  10/10(++) 2/2 (+) 10/10 (+) 
CMV 0/10 0% 2/2 (+++) 0/10 
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Table 3.  Correlation analysis of inflammatory genes expression level  
 
 
 
 
 
 
 
 
 
Ten inflamed pulp tissue samples were collected patients diagnosed with irreversible 
pulpits.  Total RNA were extracted from pulp tissue using RNeasy kit (Qiagen).  The 
expression of inflammatory genes including IL-6, IL-10, TNF-α,  NF-β and IFN-  were 
evaluated using real-time RT- CR.   he e pression levels were normali ed usin  β-actin 
gene expression level.  The Pearson correlation analysis was performed.  Significant 
positive correlations (P < 0.05) were subsequently identified between IL-6, IL-10, TNF- 
α and TNF-β; while the negative correlations between IFN- β and IL-6, IL-10, TNF- α, 
TNF-β were observed.  Shown in table were the Pearson Correlation Coefficients.  
Correlation 
analysis  IFN- β IL-10  IL-6  TNF- α   TNF- β   
IFN- β 1.00  -0.91  -0.90  -0.96  -0.94  
Il-10   1.00  0.94  0.93  0.97  
IL-6    1.00  0.93  0.95  
TNF- α      1.00  0.95  
TNF- β       1.00  
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Figure legends 
Figure 1. Comparison of bacterial DNA and RNA. Twenty inflamed pulp tissue 
samples were collected from patients diagnosed with irreversible pulpits, 10 with 
symptom of severe self-reported pain (>7 on 10-point scale of pain, Symptomatic) and 
10 without symptom of pain (Asymptomatic). Two periapical tissue samples were 
collected during apicoectomy from two asymptomatic patients with persistent periapical 
infection (Periapical).  Ten healthy pulp tissues were collected from extracted 3rd molars 
(Control).  Total DNA, RNA was extracted from pulp tissue using DNeasy and RNeasy 
kit (Qiagen).  The quantities of total bacteria, Streptococcus sp., assessed using 
quantitative qPCR.  The bacterial DNA and RNA quantities were normalized using cell 
number as indicated by cellular β-actin levels.  (A) Comparison of total bacterial DNA.  
Folds were calculated by comparison of the total bacterial DNA within the pulp tissue 
from the case group (symptomatic and asymptomatic) to the control groups (set as 1).  
Statistically significant more bacterial DNA present in pulp tissue from symptomatic 
patients than the control (P=0.004).  No statistical differences of total bacterial DNA 
were detected between symptomatic patients and asymptomatic patients (P= 0.275) or 
between asymptomatic patients and control (P=0.407).  (B) Comparison of 
Streptococcus sp. DNA.  Folds were calculated by comparison of the Streptococcus sp. 
DNA within the pulp tissue from the case group (symptomatic and asymptomatic) to the 
control groups (set as 1).  Statistically significant more Streptococcus sp. DNA present in 
pulp tissue from symptomatic (P=0.003) and asymptomatic (P=0.001) patients than the 
control, respectively. Statistically significant higher load of Streptococcus sp. DNA 
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present in pulp tissue from asymptomatic than symptomatic patients (P=0.048).  (C) 
Comparison of total bacterial RNA.  Folds were calculated by comparison of the 
bacterial RNA within the pulp tissue from the symptomatic patients and asymptomatic 
patients to the lowest detection levels (set as 1).  Bacterial RNA within the pulp tissue 
from control group and periapical tissues were below detection level.  They were set as 1 
arbitrarily.  Statistically significant more bacterial RNA present in pulp tissue from 
symptomatic patients than the asymptomatic patients (P=0.027).   
 
Figure 2. Comparison of EBV quantities. Twenty inflamed pulp tissue samples were 
collected from patients diagnosed with irreversible pulpits, 10 with symptom of severe 
self-reported pain (>7 on 10-point scale of pain, Symptomatic) and 10 without symptom 
of pain (Asymptomatic). Two periapical tissue samples were collected during 
apicoectomy from two asymptomatic patients with persistent periapical infection 
(Periapical).  Ten healthy pulp tissues were collected from extracted 3rd molars 
(Control).  Total DNA was extracted from pulp tissue using DNeasy and RNeasy kit 
(Qiagen). The quantity of EBV was assessed using qPCR.  The EBV quantities were 
normali ed usin  cell number as indicated by cellular β-actin levels.  Folds were 
calculated by comparison of the EBV quantity within the pulp tissue from the 
symptomatic and asymptomatic patients to the control groups (set as 1).  Statistically 
higher load of EBV present in pulp tissue from symptomatic than asymptomatic 
(P=0.028) patients and the control (P<0.001).   No statistically difference of EBV loads in 
pulp tissues from asymptomatic patients and the control (P=0.403) 
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Figure 3 (A) Selected inflammatory gene expression analysis in inflamed and 
healthy pulp. Ten inflamed pulp tissue samples were collected from patients diagnosed 
as irreversible pulpits and extracted 3rd molars, respectively.  Total RNA were extracted 
from pulp tissue using RNeasy kit (Qiagen).  RT-PCR analysis of selected inflammatory 
gene IL-6, IL-10 and TNF-α showed that inflammatory  enes e pressed in inflamed pulp 
tissue but not within healthy pulp tissue samples.   he e pression of cellular β-actin was 
used as control for RT-PCR analysis. (B) Comparison of IL-6 expression levels Twenty 
inflamed pulp tissue samples were collected from patients diagnosed with irreversible 
pulpits, 10 with symptom of severe self-reported pain (>7 on 10-point scale of pain, 
Symptomatic) and 10 without symptom of pain (Asymptomatic). Two periapical tissue 
samples were collected during apicoectomy from two asymptomatic patients with 
persistent periapical infection (Periapical).  Ten healthy pulp tissues were collected from 
extracted 3rd molars (Control).  Total DNA, RNA was extracted from pulp tissue using 
DNeasy and RNeasy kit (Qiagen).  Total RNA were extracted from pulp tissue using 
RNeasy kit (Qiagen).  IL-6 gene expression level in the pulp tissue was assessed using 
real-time RT- CR analysis.   he e pression of cellular β-actin was used as control for 
RT-PCR analysis. The expression of IL-6 gene was significant higher in pulp tissue from 
symptomatic patients than in asymptomatic patients (P=0.026). 
 
Figure 4. Scatter plot with regression line. Regression analysis and scatter plot were 
performed using SPSS 17.0.  (A) Regression analysis between IL-6 expression levels 
and total bacterial activities Dependent variable is IL-6 expression level.  Independent 
variable was total bacterial RNA as the indicator for bacterial activity. Significant 
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association between IL-6 expression level and total bacterial RNA activity was found 
(P=0.045). (B) Regression analysis between IL-6 expression levels and EBV 
quantities. Dependent variable is IL-6 expression level.  Independent variable was EBV 
quantity. Significant association between IL-6 expression level and EBV quantity was 
shown (P=0.025).
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Chapter 4 
 
Summary and the opportunities for future research 
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This dissertation provides both in vitro and in vivo evidences that interaction between 
bacterial and viral interaction aggravates inflammatory response.  In in vitro study, E. 
faecalis, a gram-positive species, was employed to investigate bacterial and virus, EBV, 
interaction.  We showed that a cell wall component of E. faecalis, LTA, can significantly 
re-activate latent EBV in a lymphocyte cell line.  The effect of E. faecalis on EBV was 
via TLRs mediated NF-    I b pathway.  When latent EBV presented in the cells, the 
growth and virulent gene expressions within E. faecalis had significantly increased.  In 
addition, the inflammatory response is significantly higher with the co-infection of latent 
EBV and E. faecalis.  Collectively, our results show that E. faecalis and EBV interactions 
might aggravate inflammation in vitro.  Further research is warranted in order to delineate 
the detailed cellular signal transduction pathway of E. faecalis re-activation of latently 
infected EBV.  In our study, we showed that E. faecalis LTA -mediated induction of lytic 
EBV infection is significantly reduced by the TLR2 antagonist and inhibitor of the NF-
   I b pathway, yet not fully diminished, su  estin  other possible mechanism mi ht 
exist and there might be cross-talks between these different mechanisms.  The 
mechanism by which EBV influence E. faecalis growth and virulence requires further 
investigated.  Very limited research has been done to investigate the direct interaction 
between virus and bacteria.  This is a new yet exciting research field that needs a lot of 
attention and investigation.  The current model regarding viral bacterial interaction 
proposes the interaction is indirectly through the host.  Our results showed the cellular 
inflammatory response significantly increased when co-infected with both E. faecalis and 
EBV.  It’s ! nown that E. faecalis is associated with chronic intestinal infection.  An 
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animal study is necessary to investigate whether E. faecalis and EBV synergy exist in 
vivo and contribute to the pathogenesis. 
Our in vivo study showed, for the first time, that the pro-inflammatory genes such as IL-6 
were associated with EBV viral load even after adjusting for bacterial activity, suggesting 
the possibility that EBV contributes to pulpal inflammation and consequently patient 
symptoms. The results indicated that inflammatory mediators had higher expression in 
symptomatic pulp, which might be associated with higher bacteria activity and EBV 
loads.   The bacterial profile seems different in symptomatic and asymptomatic.  For 
example, significantly more streptococci were present in asymptomatic pulp than 
symptomatic pulp.  The results support a paradigm shift in which elevated bacterial/viral 
replication and inflammation are associated with endodontic infection. The players 
(bacteria/viral species) change over the course of infection.   Studies with larger sample 
size are certainly needed to draw more definitive conclusions.    
In summary, this thesis offers in vivo and in vitro evidence for viral-bacterial synergy in 
inflammatory response.   The mechanism of the interaction between herpes virus, EBV 
and the Gram-positive bacterium, E. faecalis was explored.  More research was 
warranted in this field.   
 
 
 
 
 
